Oral Adverse Events Associated with Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma: A Structured Literature Review

Author(s):
Boers-Doets, C.B.; Epstein, J.B.; Raber-Durlacher, J.E.; Ouwerkerk, J.; Logan, R.M.; Brakenhoff, J.A.; Lacouture, M.E.; Gelderblom, H.
Published
2012
Publication type
Article / Letter to editor
Tyrosine kinase inhibitorMammalian target of rapamycin inhibitorOral adverse eventsMucositisAphthous stomatitisRenal cell carcinoma
Date issued
2012-01-31
Language
English
Is part of
hdl
1887/98141
doi
10.1634/theoncologist.2011-0111